|

TT-10 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Portage Biotech1

Indications

  • Castrate Resistant Prostate Cancer1
  • Renal Cell Cancer1
  • Colorectal Cancer (CRC)1
  • Endometrial Cancer1
  • Head and Neck Squamous Cell Carcinoma1

Los Angeles, California1 trial

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

USC Norris Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.